Ahmed A El-Gendy
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Ahmed A El-Gendy has a total of 3 co-authors. Here are the top co-authors by number of shared publications:
- Amany A. Mousa
Internal Medicine Department, Specialized Medical Hospital, Faculty of Medicine, Mansoura University, Mansoura, Egypt
1 shared publication - Amr Medhat Abbas
A Medical Physiology Department, Faculty of Medicine, Mansoura University, Mansoura, Egypt
1 shared publication - Tharwat Saad Kandil
Ayman El Nakeeb, Ahmad M Sultan, Emad Hamdy, Ehab El Hanafy, Ehab Atef, Tarek Salah, Ahmed A ElGeidie, Tharwat Kandil, Mohamed El Shobari, Gamal El Ebidy, Gastroenterology surgical center, Mansoura University, Daqahlia 35516, Egypt
1 shared publication
Latest Publications
- Open Access
- 18 January 2010
- Published by Springer Nature in BMC Gastroenterology
- Vol. 10 (1) , 7
The potential therapeutic effect of melatonin in gastro-esophageal reflux disease
Gastro-Esophageal Reflux Disease (GERD) defined as a condition that develops when the reflux of stomach contents causes troublesome symptoms and/or complications. Many drugs are used for the treatment of GERD such as omeprazole (a proton pump inhibitor) which is a widely used antiulcer drug demonstrated to protect against esophageal mucosal injury. Melatonin has been found to protect the gastrointestinal mucosa from oxidative damage caused by reactive oxygen species in different experimental ulcer models. The aim of this study is to evaluate the role of exogenous melatonin in the treatment of reflux disease in humans either alone or in combination with omeprazole therapy.
- 18 January 2010
- Published by Springer Nature in BMC Gastroenterology
- Vol. 10 (1) , 7
Open AccessThe potential therapeutic effect of melatonin in gastro-esophageal reflux disease
Gastro-Esophageal Reflux Disease (GERD) defined as a condition that develops when the reflux of stomach contents causes troublesome symptoms and/or complications. Many drugs are used for the treatment of GERD such as omeprazole (a proton pump inhibitor) which is a widely used antiulcer drug demonstrated to protect against esophageal mucosal injury. Melatonin has been found to protect the gastrointestinal mucosa from oxidative damage caused by reactive oxygen species in different experimental ulcer models. The aim of this study is to evaluate the role of exogenous melatonin in the treatment of reflux disease in humans either alone or in combination with omeprazole therapy.